The Vascular Effects of Carvedilol Controlle Release (CR) + Lisinopril Versus Lisinopril + Hydrochlorothiazide (HCTZ) in Abdominally Obese Hypertensive Patients

Trial Profile

The Vascular Effects of Carvedilol Controlle Release (CR) + Lisinopril Versus Lisinopril + Hydrochlorothiazide (HCTZ) in Abdominally Obese Hypertensive Patients

Completed
Phase of Trial: Phase III

Latest Information Update: 07 Nov 2013

At a glance

  • Drugs Carvedilol (Primary) ; Hydrochlorothiazide; Lisinopril
  • Indications Hypertension
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 01 Feb 2012 Results published in the Journal of Clinical Hypertension (Greenwich).
    • 10 Sep 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 09 Sep 2010 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top